The Cutaneous Lymphoma Foundation is pleased to provide the following published research abstracts and reports to provide an outlook on cutaneous lymphoma research:
CLF CEO, Susan Thornton had the chance to sit down with Dr Rick Straub, Senior VP and Chief Medical Officer of Soligenix, Inc. recently to talk about their clinical trial for treating early stage cutaneous lymphoma. The treatment process uses a new topical photosensitizing agent (synthetic hypericin) and fluorescent light. We invite you to view Susan's interview with Dr. Straub and share with us your thoughts on this new potential treatment.
Journal of the American Academy of Dermatology, February 2015, Volume 72, Issue 2, Pages 286–292, http://www.jaad.org
OncoTherapy Network, February 3, 2015, www.oncotherapynetwork.com
To read abstract:
Blood Journal, January 27, 2015, www.bloodjournal.org
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.